Literature DB >> 31008323

Intra-arterial mechanical thrombectomy stent retrievers and aspiration devices in the treatment of acute ischaemic stroke: A systematic review and meta-analysis with trial sequential analysis.

Darren Flynn1, Richard Francis2, Kristoffer Halvorsrud1, Eduardo Gonzalo-Almorox3, Dawn Craig1, Shannon Robalino1, Peter McMeekin4, Adela Cora2, Joyce Balami5, Gary A Ford2,6, Phil White2.   

Abstract

PURPOSE: Intra-arterial mechanical thrombectomy combined with appropriate patient selection (image-based selection of acute ischaemic stroke patients with large artery occlusion) yields improved clinical outcomes. We conducted a systematic review and meta-analysis, with trial sequential analysis to understand the benefits, risks and impact of new trials reporting in 2016 on the magnitude/certainty of the estimates for clinical effectiveness and safety of mechanical thrombectomy.
METHOD: Random effects' models were conducted of randomised clinical trials comparing mechanical thrombectomy (stent retriever or aspiration devices) with/without adjuvant intravenous thrombolysis with intravenous thrombolysis and other forms of best medical/supportive care in the treatment of acute ischaemic stroke. Study inclusion and risk of bias were assessed independently by two reviewers. Functional independence (modified Rankin Scale 0-2) and mortality at 90 days, including symptomatic intracranial haemorrhage rate were extracted. Trial sequential analysis established the strength of the evidence derived from the meta-analyses.
FINDINGS: Eight trials of mechanical thrombectomy with a total sample size of 1841 (916 patients treated with mechanical thrombectomy and 925 treated without mechanical thrombectomy) fulfilled review inclusion criteria. The three most recent trials more precisely defined the effectiveness of mechanical thrombectomy (modified Rankin Scale 0 to 2; OR = 2.07, 95% CI = 1.70 to 2.51 based on data from eight trials versus OR = 2.39, 95% CI = 1.88 to 3.04 based on data from five trials). Meta-analyses showed no effect on mortality (OR = 0.81, 95% CI = 0.61 to 1.07) or symptomatic intracranial haemorrhage (OR = 1.22, 95% CI = 0.80 to 1.85) as found in analysis of first five trials. Trial sequential analysis indicated that the information size requirement was fulfilled to conclude the evidence for mechanical thrombectomy is robust. DISCUSSION: The impact of three recent trials on effectiveness and safety of mechanical thrombectomy was a more precise pooled effect size for functional independence. Trial sequential analysis demonstrated sufficient evidence for effectiveness and safety of mechanical thrombectomy.
CONCLUSION: No further trials of mechanical thrombectomy versus no mechanical thrombectomy are indicated to establish clinical effectiveness. Uncertainty remains as to whether mechanical thrombectomy reduces mortality or increases risk of symptomatic intracranial haemorrhage.

Entities:  

Keywords:  Acute ischaemic stroke; intra-arterial thrombolysis; intravenous thrombolysis; meta-analysis; sequential trial analysis; stent retriever; systematic review; thrombectomy

Year:  2017        PMID: 31008323      PMCID: PMC6453187          DOI: 10.1177/2396987317719362

Source DB:  PubMed          Journal:  Eur Stroke J        ISSN: 2396-9873


  33 in total

1.  FUNCTIONAL EVALUATION: THE BARTHEL INDEX.

Authors:  F I MAHONEY; D W BARTHEL
Journal:  Md State Med J       Date:  1965-02

2.  Time to treatment with intravenous alteplase and outcome in stroke: an updated pooled analysis of ECASS, ATLANTIS, NINDS, and EPITHET trials.

Authors:  Kennedy R Lees; Erich Bluhmki; Rüdiger von Kummer; Thomas G Brott; Danilo Toni; James C Grotta; Gregory W Albers; Markku Kaste; John R Marler; Scott A Hamilton; Barbara C Tilley; Stephen M Davis; Geoffrey A Donnan; Werner Hacke; Kathryn Allen; Jochen Mau; Dieter Meier; Gregory del Zoppo; D A De Silva; K S Butcher; M W Parsons; P A Barber; C Levi; C Bladin; G Byrnes
Journal:  Lancet       Date:  2010-05-15       Impact factor: 79.321

3.  The impact of recanalization on ischemic stroke outcome: a meta-analysis.

Authors:  Joung-Ho Rha; Jeffrey L Saver
Journal:  Stroke       Date:  2007-02-01       Impact factor: 7.914

4.  Low rates of acute recanalization with intravenous recombinant tissue plasminogen activator in ischemic stroke: real-world experience and a call for action.

Authors:  Rohit Bhatia; Michael D Hill; Nandavar Shobha; Bijoy Menon; Simerpreet Bal; Puneet Kochar; Tim Watson; Mayank Goyal; Andrew M Demchuk
Journal:  Stroke       Date:  2010-09-09       Impact factor: 7.914

5.  Intravenous tissue plasminogen activator and flow improvement in acute ischemic stroke patients with internal carotid artery occlusion.

Authors:  Ioannis Christou; Robert A Felberg; Andrew M Demchuk; W Scott Burgin; Marc Malkoff; James C Grotta; Andrei V Alexandrov
Journal:  J Neuroimaging       Date:  2002-04       Impact factor: 2.486

6.  Thrombolysis with alteplase 3 to 4.5 hours after acute ischemic stroke.

Authors:  Werner Hacke; Markku Kaste; Erich Bluhmki; Miroslav Brozman; Antoni Dávalos; Donata Guidetti; Vincent Larrue; Kennedy R Lees; Zakaria Medeghri; Thomas Machnig; Dietmar Schneider; Rüdiger von Kummer; Nils Wahlgren; Danilo Toni
Journal:  N Engl J Med       Date:  2008-09-25       Impact factor: 91.245

7.  Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke.

Authors:  Randall T Higashida; Anthony J Furlan; Heidi Roberts; Thomas Tomsick; Buddy Connors; John Barr; William Dillon; Steven Warach; Joseph Broderick; Barbara Tilley; David Sacks
Journal:  Stroke       Date:  2003-07-17       Impact factor: 7.914

8.  Multivariable analysis of outcome predictors and adjustment of main outcome results to baseline data profile in randomized controlled trials: Safe Implementation of Thrombolysis in Stroke-MOnitoring STudy (SITS-MOST).

Authors:  Nils Wahlgren; Niaz Ahmed; Niclas Eriksson; Franz Aichner; Erich Bluhmki; Antoni Dávalos; Terttu Erilä; Gary A Ford; Martin Grond; Werner Hacke; Michael G Hennerici; Markku Kaste; Martin Köhrmann; Vincent Larrue; Kennedy R Lees; Thomas Machnig; Risto O Roine; Danilo Toni; Geert Vanhooren
Journal:  Stroke       Date:  2008-10-16       Impact factor: 7.914

Review 9.  Recombinant tissue plasminogen activator for acute ischaemic stroke: an updated systematic review and meta-analysis.

Authors:  Joanna M Wardlaw; Veronica Murray; Eivind Berge; Gregory del Zoppo; Peter Sandercock; Richard L Lindley; Geoff Cohen
Journal:  Lancet       Date:  2012-05-23       Impact factor: 79.321

10.  Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement.

Authors:  David Moher; Alessandro Liberati; Jennifer Tetzlaff; Douglas G Altman
Journal:  PLoS Med       Date:  2009-07-21       Impact factor: 11.069

View more
  7 in total

1.  The cost of providing mechanical thrombectomy in the UK NHS: a micro-costing study.

Authors:  Joyce S Balami; Diamuid Coughlan; Phil M White; Peter McMeekin; Darren Flynn; Christine Roffe; Indira Natarajan; Jayan Chembala; Sanjeev Nayak; Ivan Wiggam; Peter Flynn; Robert Simister; Yazen Sammaraiee; Don Sims; Kurdow Nader; Anand Dixit; Dawn Craig; Hannah Lumley; Stephen Rice; David Burgess; Lisa Foddy; Emer Hopkins; Beverley Hudson; Rachael Jones; Martin A James; Alastair M Buchan; Gary A Ford; Alastair M Gray
Journal:  Clin Med (Lond)       Date:  2020-05       Impact factor: 2.659

2.  Maximising access to thrombectomy services for stroke in England: A modelling study.

Authors:  Michael Allen; Kerry Pearn; Martin James; Gary A Ford; Phil White; Anthony G Rudd; Peter McMeekin; Ken Stein
Journal:  Eur Stroke J       Date:  2018-07-19

3.  Estimating the effectiveness and cost-effectiveness of establishing additional endovascular Thrombectomy stroke Centres in England: a discrete event simulation.

Authors:  Peter McMeekin; Darren Flynn; Mike Allen; Diarmuid Coughlan; Gary A Ford; Hannah Lumley; Joyce S Balami; Martin A James; Ken Stein; David Burgess; Phil White
Journal:  BMC Health Serv Res       Date:  2019-11-08       Impact factor: 2.655

4.  Safety and Efficacy of Mechanical Thrombectomy Using Tigertriever as a Rescue Device After Failed Aspiration-Single Center Experience.

Authors:  Piotr Piasecki; Marek Wierzbicki; Jerzy Narloch
Journal:  Front Neurol       Date:  2021-01-21       Impact factor: 4.003

5.  Meta-Analysis of the Effectiveness and Safety of Intravenous Thrombolysis in Patients with Acute Cerebral Infarction.

Authors:  Huili Wu; Weiping Gong; Yanyan Tang; Wuhua Xu; Ying Zhou; Xianjun Liu
Journal:  Comput Math Methods Med       Date:  2021-12-07       Impact factor: 2.238

6.  National implementation of reperfusion for acute ischaemic stroke in England: How should services be configured? A modelling study.

Authors:  Michael Allen; Kerry Pearn; Gary A Ford; Phil White; Anthony G Rudd; Peter McMeekin; Ken Stein; Martin James
Journal:  Eur Stroke J       Date:  2021-12-23

7.  In vitro testing of a funnel-shaped tip catheter model to decrease clot migration during mechanical thrombectomy.

Authors:  Yasemin Tanyildizi; Emily Payne; Tiemo Gerber; Larissa Seidman; Axel Heimann; Oliver Kempski; Doris Leithner; Andreas Garcia-Bardon; Roman Kloeckner; Felix Hahn; Naureen Keric; Julia Masomi-Bornwasser; Marc A Brockmann; Stefanie Kirschner
Journal:  Sci Rep       Date:  2020-01-20       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.